- « Previous
- Clinical Pharmacology
- Next »
Androderm
CLINICAL PHARMACOLOGY
Androderm
Androderm (testosterone transdermal system) delivers physiologic amounts of testosterone producing circulating testosterone concentrations that approximate the normal circadian rhythm of healthy young men.
Testosterone
Androderm (testosterone transdermal system) delivers testosterone, the primary androgenic hormone. Testosterone is responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of the prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as facial, public, chest, and axillary hair; laryngeal enlargement; vocal cord thickening; and alterations in body musculature and fat distribution.
Male hypogonadism results from insufficient secretion of testosterone and is characterized by low serum testosterone concentrations. Symptoms associated with male hypogonadism include the following: impotence and decreased sexual desire; fatigue and loss of energy; mood depression; and regression of secondary sexual characteristics.
General Androgen Effects
Androgens promote retention of nitrogen, sodium, potassium, and phosphorus, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.
Androgens are also responsible for the growth spurt of adolescence and for the eventual termination of linear growth that is brought about by the fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process.
Androgens have been reported to stimulate the production of red blood cells by enhancing erythropoietin production.
During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary LH secretion. With large doses of exogenous androgens, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH) secretion.
There is a lack of substantial evidence that androgens are effective in accelerating fracture healing or in shortening post-surgical convalescence.
Pharmacokinetics
Following Androderm (testosterone transdermal system) application to non-scrotal skin, testosterone is continuously absorbed during the 24-hour dosing period. Daily application of Androderm at approximately 10 PM results in a serum testosterone concentration profile that mimics the normal circadian variation observed in healthy young men (Fig. 2 below). Maximum concentrations occur in the early morning hours with minimum concentrations in the evening (Table 1 below).

Generic Name: Testosterone Transdermal System
- « Previous
- Clinical Pharmacology
- Next »
Rethinking HRT
In 2002, researchers linked estrogen therapy to an increased risk for breast cancer, heart attack and stroke. Now it looks like the hormone is finding its way back into medicine cabinets. See more WebMD Videos »
WebMD Daily
Get breaking medical news.
